Screening of the Possible Risk Factors for Borderline Personality Disorders and Validation of Maclean Instrument
1 other identifier
observational
100
1 country
1
Brief Summary
Borderline personality disorder is a mental illness that severely impacts a person's ability to regulate their emotions. This loss of emotional control can increase impulsivity, affect how a person feels about themselves, and negatively impact their relationships with others. In fact, the societal impact of BPDs might be found in emotional suffering, disability and economic burden. In addition in BPD, the suicide rate might be as high as 8-10%. the presence of BPD also interferes with response to treatment of physical and psychiatric comorbidities, such as migraine, HIV, anxiety disorders and substance use disorders. Furthermore, BPD in particular, are associated with high rates of unemployment, absences from work and inefficiency at work, with only 25% of patients suffering from BPD working full time and 40% receiving disability payments. Accordingly, early detection and management would be of great societal and economic impact. Our Study aim is to validate the Arabic version of Maclean Instrument for screening and detection of BPD and and investigate the possible risk factors associated with that disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2023
CompletedFirst Posted
Study publicly available on registry
April 26, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedSeptember 7, 2023
September 1, 2023
4 months
April 16, 2023
September 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
validation of Arabic version of Maclean Instrument
detection of reliability and consistency
6 months
Detection of Borderline personality disorder Risk factors in Egyptians students
survey
6 months
Study Arms (1)
one group
Interventions
Eligibility Criteria
adults
You may qualify if:
- age group (18-28 years old )
- University students
You may not qualify if:
- less than 18 years old
- more than 28 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
October University for modern sciences and arts
Giza, Egypt
Related Publications (1)
Dias DS, Natividade JC. Brazilian adaptation of the McLean Screening Instrument for Borderline Personality Disorder. Trends Psychiatry Psychother. 2024;46:e20220486. doi: 10.47626/2237-6089-2022-0486. Epub 2022 Oct 18.
PMID: 36257605RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
sara Eladawy, PhD
MSA university
- STUDY DIRECTOR
mohamed hafez
biostatistician, biomedical informatics medical research institute Alexandria University
- STUDY CHAIR
mohamed emad
biostatistician, biomedical informatics, medical research institute, Alexandria University
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of clinical pharmacy
Study Record Dates
First Submitted
April 16, 2023
First Posted
April 26, 2023
Study Start
May 1, 2023
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
September 7, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share